Alport syndrome and thin basement membrane nephropathy. (Q53546427)

15 May 2018

review article

1 reference

title

Alport syndrome and thin basement membrane nephropathy. (English)

1 reference

15 May 2018

1 reference

Paul Scott Thorner

1

1 reference

15 May 2018

publication date

6 June 2007

1 reference

15 May 2018

published in

The Nephron Journals

1 reference

15 May 2018

volume

106

1 reference

15 May 2018

issue

2

1 reference

15 May 2018

page(s)

c82-8

1 reference

15 May 2018

The inner ear of dogs with X-linked nephritis provides clues to the pathogenesis of hearing loss in X-linked Alport syndrome

cites work

1 reference

COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome

21 January 2018

1 reference

Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes.

21 January 2018

1 reference

Integrin alpha1beta1 and transforming growth factor-beta1 play distinct roles in alport glomerular pathogenesis and serve as dual targets for metabolic therapy

21 January 2018

1 reference

Delayed chemokine receptor 1 blockade prolongs survival in collagen 4A3-deficient mice with Alport disease.

21 January 2018

1 reference

A human-mouse chimera of the alpha3alpha4alpha5(IV) collagen protomer rescues the renal phenotype in Col4a3-/- Alport mice.

21 January 2018

1 reference

Transfer of the alpha 5(IV) collagen chain gene to smooth muscle restores in vivo expression of the alpha 6(IV) collagen chain in a canine model of Alport syndrome

21 January 2018

1 reference

Type IV collagen induces podocytic features in bone marrow stromal stem cells in vitro.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000101802

1 reference

15 May 2018

PubMed ID

17570934

1 reference

15 May 2018